← All indications
Pleural Effusion
Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself.
Subtype terms (1)
More specific conditions that are subtypes of Pleural Effusion in the MeSH hierarchy.
- Pleural Effusion, Malignant
57 drugs (39 approved, 18 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (10)
Phase 3 trials (3)
Phase 2 trials (5)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (20)
- Abnoba
- Roche
- Genentech
- National Cancer Institute (NCI)
- Eastern Cooperative Oncology Group
- Kaiser Permanente
- Maria Vittoria Hospital
- North Central Cancer Treatment Group
- Radiation Therapy Oncology Group
- University of South Florida
- Mayo Clinic
- University of California, Los Angeles
- University of Ulsan
- Advocate Healthcare
- FORSCHUNGSINSTITUT HAVELHOHE
- Busan University
- Chiangmai University
- Free University of Brussels
- Chonnam National University
- People's Liberation Army of China
Organization Involved with Phase 2 Indications (35)
- Amgen
- AstraZeneca
- Eli Lilly
- Aventis
- CareFusion
- Shenzhen SiBiono GeneTech Co.,Ltd
- Simcere Pharmaceutical Co., Ltd
- CytRx
- National Heart, Lung, and Blood Institute (NHLBI)
- Huazhong University of Science and Technology
- Cancer and Leukemia Group B (CALGB)
- University of Washington
- Guangzhou Medical University
- Hospital Infanta Sofia
- Johns Hopkins University
- McMaster University
- Radboud University
- University of Kentucky
- University of Ottawa
- University of Rochester
- Peking University
- University of Chicago
- Zhejiang University
- Department of Defense
- Guangzhou University
- University of Oxford
- University of Texas at Houston
- University of Sao Paulo
- University of North Carolina at Chapel Hill
- Kentucky Lung Cancer Research Program
- +5 more
Organization Involved with Phase 1 Indications (18)
- Genelux
- Candel Therapeutics
- Biogen
- Bayer
- University of Pennsylvania
- Cornell University
- Eastern Regional Medical Center
- Ohio State University
- University of Ibadan
- University of Lausanne
- University of Virginia
- University of Zurich
- CHU Henri Mondor
- Curie Institute
- City of Hope National Medical Center
- Technion University
- Clover Biopharmaceuticals
- Sichuan Clover Biopharmaceuticals, Inc.
Organization Involved with Other Experimental Indications (9)